Maintenance. We are currently updating the site. Please check back shortly
Members login
  • TrustLaw
  • Members Portal
Subscribe

Ten rivals join with NIH to search for new drugs - WSJ

Source: Reuters - Tue, 4 Feb 2014 07:34 AM
Author: Reuters
hum-dis
Tweet Recommend Google + LinkedIn Bookmark Email Print
Leave us a comment

Feb 4 (Reuters) - Ten big rival drug companies have formed a pact to cooperate on a government-backed effort to accelerate the discovery of new drugs, the Wall Street Journal reported.

The companies and the National Institutes of Health (NIH) will share scientists, tissue and blood samples, and data, to identify targets for new drugs for diseases such as Alzheimer's, Type 2 diabetes, rheumatoid arthritis and lupus, the Journal said.

The collaboration, called the Accelerating Medicines Partnership, will cost about $230 million and involves drugmakers such as Bristol-Myers Squibb Co, Johnson & Johnson, GlaxoSmithKline, Takeda Pharmaceuticals and Sanofi. ()

The agreement prohibits participants from using any discovery for their own drug development until the project makes data public on that discovery.

The NIH, GlaxoSmithKline, Bristol-Myers, Sanofi, Takeda, and Johnson & Johnson could not be immediately reached for comments by Reuters.

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus
TOPICAL CONTENT
Topical content
LATEST SLIDESHOW

Latest slideshow

See allSee all
FEATURED JOBS
Featured jobs